Site-Wide License

Showing 25–36 of 279 results

  • Select options

    Phase II/III CRO Benchmarking—Small Pharma Market (3rd Ed.)

    $4,550.00 – $9,100.00
  • Select options

    Bioprocessing Market Outlook: 2022-2027

    $5,650.00 – $11,300.00
  • Select options

    Phase II/III Market Outlook: 2022-2026

    $5,650.00 – $11,300.00
  • Select options

    Clinical Logistics Market Dynamics

    $5,650.00 – $11,300.00
  • Select options

    Highly Potent API Market Outlook

    $5,650.00 – $11,300.00
  • Select options

    Biologic API CDMO Benchmarking for New & Emerging Biopharma

    $4,550.00 – $9,100.00
  • Select options

    Phase II/III CRO Benchmarking (14th Ed.)

    $6,750.00 – $13,500.00
  • Select options

    Phase I CRO Benchmarking (14th Ed.)

    $6,750.00 – $13,500.00
  • Select options

    Small Molecule Drug Product CDMO Benchmarking (5th Ed.)

    $6,750.00 – $13,500.00
  • Select options

    Small Molecule API CDMO Benchmarking (7th Ed.)

    $6,750.00 – $13,500.00
  • Select options

    Biologic API CDMO Benchmarking (7th Ed.)

    $6,750.00 – $13,500.00
  • Select options

    Biologic Drug Product CDMO Benchmarking (5th Ed.)

    $6,750.00 – $13,500.00